13FPulse
中
AV

AVIR ATEA PHARMACEUTICALS INC

2026Q2 · CUSIP 04683R106 · Sector: Healthcare & Biotech

Normal

Fund flows are within the usual range

Funds that own it
124
Institutions that reported holding it to the SEC
Net decrease in holders
2
Last quarter 126 → now 124
How unusual is that
Below average
Stronger than only 28% of US stocks
What the filings say, in one paragraph

124 funds held AVIR at the end of 2026Q2, down 2 from the quarter before. Fund flows are within the usual range — nothing unusual. On the business itself, return on equity is -81.0%. AVIR has had 2 buying rushes in its history, and the price moved -47.4% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2021Q1: holders=81 2021Q2: holders=103 2021Q3: holders=140 2021Q4: holders=142 2022Q1: holders=127 2022Q2: holders=128 2022Q3: holders=126 2022Q4: holders=131 2023Q1: holders=128 2023Q2: holders=133 2023Q3: holders=118 2023Q4: holders=108 2024Q1: holders=112 2024Q2: holders=105 2024Q3: holders=108 2024Q4: holders=106 2025Q1: holders=103 2025Q2: holders=106 2025Q3: holders=114 2025Q4: holders=111 2026Q1: holders=126 2026Q2: holders=124 -37 -18.5 +0 +18.5 +37 72111150 21Q121Q322Q122Q323Q123Q324Q124Q325Q125Q326Q126Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 2 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2021Q3 Top 5% -30.3% -16.6%
2021Q2 Top 20% -61.1% -78.2%

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
70
Change in large funds
-4
Total value they hold
$276M
Funds buying for the first time
20
Funds that sold out entirely
22
Price change that quarter
+29.2%
Funds holding puts (bearish)
0
Funds holding calls (bullish)
1

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
—
EPS (TTM)
$-2.08
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Net margin
—
ROE
-81.0%
Debt ratio
12.1%
FCF (TTM)
—
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2021-09-30: EPS -0.34 2021-12-31: EPS 1.35 2022-03-31: EPS -0.51 2022-06-30: EPS -0.38 2022-09-30: EPS -0.10 2022-12-31: EPS -0.40 2023-03-31: EPS -0.43 2023-06-30: EPS -0.34 2023-09-30: EPS -0.40 2023-12-31: EPS -0.46 2024-03-31: EPS -0.75 2024-06-30: EPS -0.48 2024-09-30: EPS -0.37 2024-12-31: EPS -0.40 2025-03-31: EPS -0.40 2025-06-30: EPS -0.44 2025-09-30: EPS -0.53 2025-12-31: EPS -0.57 2026-03-31: EPS -0.57 2026-06-30: EPS -0.41 -0.82 0.33 1.49 20212022202320242025202606/26 EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
12 44 76 20222023202420252026

P/E = close around day 47 after quarter-end ÷ TTM EPS then; this is a consistent valuation date, not the company’s actual filing date; loss quarters hidden

Quarterly free cash flow
-59M130M319M 20192020202120222023202420252026
Latest quarter $-22M (2022-12-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.